144 related articles for article (PubMed ID: 12931573)
21. Pseudoepidemic of urinary tract infections due to Trichosporon beigelii.
Stone J; Manasse R
Infect Control Hosp Epidemiol; 1989 Jul; 10(7):312-5. PubMed ID: 2663974
[TBL] [Abstract][Full Text] [Related]
22. Disseminated Trichosporon infection. A case report and immunohistochemical study.
Nasu K; Akizuki S; Yoshiyama K; Kikuchi H; Higuchi Y; Yamamoto S
Arch Pathol Lab Med; 1994 Feb; 118(2):191-4. PubMed ID: 8311664
[TBL] [Abstract][Full Text] [Related]
23. Successful outpatient treatment of Trichosporon beigelii peritonitis with oral fluconazole.
Melez KA; Cherry J; Sanchez C; Ettinger RB; Walsh TJ
Pediatr Infect Dis J; 1995 Dec; 14(12):1110-3. PubMed ID: 8745028
[No Abstract] [Full Text] [Related]
24. Trichosporon beigelii pneumonia in patients with hematologic malignancies.
Tashiro T; Nagai H; Nagaoka H; Goto Y; Kamberi P; Nasu M
Chest; 1995 Jul; 108(1):190-5. PubMed ID: 7606957
[TBL] [Abstract][Full Text] [Related]
25. Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
Araujo Ribeiro M; Alastruey-Izquierdo A; Gomez-Lopez A; Rodriguez-Tudela JL; Cuenca-Estrella M
Rev Iberoam Micol; 2008 Dec; 25(4):221-5. PubMed ID: 19071890
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical identification of Trichosporon beigelii in histologic section by immunoperoxidase method.
Kobayashi M; Kotani S; Fujishita M; Taguchi H; Moriki T; Enzan H; Miyoshi I
Am J Clin Pathol; 1988 Jan; 89(1):100-5. PubMed ID: 3276138
[TBL] [Abstract][Full Text] [Related]
27. Molecular identification, genotyping, and antifungal susceptibility testing of clinically relevant Trichosporon species from Argentina.
Taverna CG; Córdoba S; Murisengo OA; Vivot W; Davel G; Bosco-Borgeat ME
Med Mycol; 2014 May; 52(4):356-66. PubMed ID: 24682113
[TBL] [Abstract][Full Text] [Related]
28. Breast implant infection caused by Trichosporon beigelii.
Reddy BT; Torres HA; Kontoyiannis DP
Scand J Infect Dis; 2002; 34(2):143-4. PubMed ID: 11928852
[TBL] [Abstract][Full Text] [Related]
29. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
[TBL] [Abstract][Full Text] [Related]
30. [The in vitro antifungal activities of fluconazole against pathogenic yeasts recently isolated from clinical specimens].
Yamaguchi H; Igari J; Kume H; Abe M; Oguri T; Kanno H; Kawakami S; Okuzumi K; Fukayama M; Ito A; Kawata K; Uchida K
Jpn J Antibiot; 1997 Sep; 50(9):799-805. PubMed ID: 9394240
[TBL] [Abstract][Full Text] [Related]
31. [A case of Trichosporon beigelii peritonitis in CAPD].
Muramatsu H; Kume H; Hojo M; Iitaka K; Okudaira M; Ohtani H
Kansenshogaku Zasshi; 1992 Aug; 66(8):1129-32. PubMed ID: 1402121
[TBL] [Abstract][Full Text] [Related]
32. Central catheter infection by Trichosporon beigelii after autologous blood stem cell transplantation. A case report and review of the literature.
Vasta S; Menozzi M; Scimé R; Indovina A; Speciale A; Liberti G; Spanò C; Majolino I
Haematologica; 1993; 78(1):64-7. PubMed ID: 8098313
[TBL] [Abstract][Full Text] [Related]
33. Onychomycosis and Trichosporon beigelii in Korea.
Han MH; Choi JH; Sung KJ; Moon KC; Koh JK
Int J Dermatol; 2000 Apr; 39(4):266-9. PubMed ID: 10809974
[TBL] [Abstract][Full Text] [Related]
34. [Two cases of Trichosporon beigelii pneumonia in immunocompromised hosts].
Onishi T; Fujita J; Ikeda K; Hata Y; Yamaji Y; Shiotani T; Takahara J; Kuwahara H; Sato A; Uda K
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Mar; 29(3):365-71. PubMed ID: 2067158
[TBL] [Abstract][Full Text] [Related]
35. Molecular and antifungal susceptibility study on trichosporonemia and emergence of Trichosporon mycotoxinivorans as a bloodstream pathogen.
Dabas Y; Xess I; Kale P
Med Mycol; 2017 Jul; 55(5):518-527. PubMed ID: 27816903
[TBL] [Abstract][Full Text] [Related]
36. Urinary tract infection by Trichosporon asahii.
Sood S; Pathak D; Sharma R; Rishi S
Indian J Med Microbiol; 2006 Oct; 24(4):294-6. PubMed ID: 17185852
[TBL] [Abstract][Full Text] [Related]
37. Voriconazole serum concentrations in an infant treated for Trichosporon beigelii infection.
Maples HD; Stowe CD; Saccente SL; Jacobs RF
Pediatr Infect Dis J; 2003 Nov; 22(11):1022-4. PubMed ID: 14628778
[No Abstract] [Full Text] [Related]
38. Trichosporon beigelii infection: a review.
Hoy J; Hsu KC; Rolston K; Hopfer RL; Luna M; Bodey GP
Rev Infect Dis; 1986; 8(6):959-67. PubMed ID: 3541129
[TBL] [Abstract][Full Text] [Related]
39. Disseminated infection with Trichosporon beigelii.
Walling DM; McGraw DJ; Merz WG; Karp JE; Hutchins GM
Rev Infect Dis; 1987; 9(5):1013-9. PubMed ID: 3479819
[TBL] [Abstract][Full Text] [Related]
40. Genital white piedra: epidemiology, microbiology, and therapy.
Kalter DC; Tschen JA; Cernoch PL; McBride ME; Sperber J; Bruce S; Wolf JE
J Am Acad Dermatol; 1986 Jun; 14(6):982-93. PubMed ID: 3722493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
